Editorial: 21st century advances in type 1 diabetes research and immunotherapy
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1213417/full |
_version_ | 1797828878944698368 |
---|---|
author | David Bleich |
author_facet | David Bleich |
author_sort | David Bleich |
collection | DOAJ |
first_indexed | 2024-04-09T13:12:35Z |
format | Article |
id | doaj.art-9584278f2b414f23826dcd1f84fc56a6 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-04-09T13:12:35Z |
publishDate | 2023-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-9584278f2b414f23826dcd1f84fc56a62023-05-12T06:36:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-05-011410.3389/fimmu.2023.12134171213417Editorial: 21st century advances in type 1 diabetes research and immunotherapyDavid Bleichhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1213417/fulltype 1 diabetesT cellsimmunologymicrobiomeneoantigenGAD 65 |
spellingShingle | David Bleich Editorial: 21st century advances in type 1 diabetes research and immunotherapy Frontiers in Immunology type 1 diabetes T cells immunology microbiome neoantigen GAD 65 |
title | Editorial: 21st century advances in type 1 diabetes research and immunotherapy |
title_full | Editorial: 21st century advances in type 1 diabetes research and immunotherapy |
title_fullStr | Editorial: 21st century advances in type 1 diabetes research and immunotherapy |
title_full_unstemmed | Editorial: 21st century advances in type 1 diabetes research and immunotherapy |
title_short | Editorial: 21st century advances in type 1 diabetes research and immunotherapy |
title_sort | editorial 21st century advances in type 1 diabetes research and immunotherapy |
topic | type 1 diabetes T cells immunology microbiome neoantigen GAD 65 |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1213417/full |
work_keys_str_mv | AT davidbleich editorial21stcenturyadvancesintype1diabetesresearchandimmunotherapy |